PU files patents for green nanoplatform in skincare and pharma

Chandigarh: Panjab University has filed Indian and international patents for a new green nanomicelle platform developed by Professor Indu Pal Kaur and her PhD scholars Bakr Ahmed and Simrandeep Kaur.

The solvent-free, eco-friendly technology enables targeted delivery of sensitive bioactives such as peptides, herbal extracts, cannabinoids, vitamins, proteins, and small molecules.These components have applications in pharmaceuticals, nutraceuticals, cosmetics, paediatrics, veterinary care, and wellness products.

The platform is scalable and designed for clean-label processes, with formulations developed at room temperature. Minimal use of USFDA-approved solvents is allowed to accommodate poorly soluble actives without compromising safety or scalability. The technology has already been transferred to an industrial partner for skincare and cosmetics applications, marking a key step in academia-industry collaboration.

Professor Indu Pal Kaur, who leads the IPK Lab at Panjab University, described the innovation as affordable and adaptable, supporting both MSMEs and global companies in developing safe and sustainable products. Her lab focuses on turning research challenges into practical solutions, with a strong emphasis on long-term partnerships and technology transfer.
The university’s Centre for Industry-Institute Partnership Programme, established in 1996, plays a vital role in fostering innovation through revenue-sharing models between faculty and the institution.

Panjab University vice-chancellor Renu Vig said the university takes pride in translating research into industry-relevant innovations that improve lives and enhance its academic reputation.
With more than 22 patents granted and 17 filed, Professor Kaur’s work highlights the growing importance of intellectual property in India’s innovation ecosystem.

Related Posts

Iran War Pushes Up Prices Of Raw Material In Pharma Industries: Will Vitamins, Antibiotics Be Costlier?

The rise in raw material costs cannot immediately be passed on to patients as prices of many medicines in India are regulated by the National Pharmaceutical Pricing Authority. The ongoing…

Maharashtra, Gujarat & Uttarakhand lead in action against misleading ads

New Delhi: The state governments of Maharashtra, Gujarat, and Uttarakhand are the front runners in taking action against the complaints they received on misleading and objectionable advertisements related to Ayush…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Iran War Pushes Up Prices Of Raw Material In Pharma Industries: Will Vitamins, Antibiotics Be Costlier?

Iran War Pushes Up Prices Of Raw Material In Pharma Industries: Will Vitamins, Antibiotics Be Costlier?

Maharashtra, Gujarat & Uttarakhand lead in action against misleading ads

Maharashtra, Gujarat & Uttarakhand lead in action against misleading ads

Sakeena Itoo reviews performance, functioning of JKMSCL

Sakeena Itoo reviews performance, functioning of JKMSCL

Dr Arun Prasad gets Recognition in London for Global Impact

Dr Arun Prasad gets Recognition in London for Global Impact

Karnataka State Information Commission slaps ₹1 lakh penalty on BDA official for failing to provide information

Karnataka State Information Commission slaps ₹1 lakh penalty on BDA official for failing to provide information

NSQ reporting nearly doubles in 2025, buoyed by greater state participation

NSQ reporting nearly doubles in 2025, buoyed by greater state participation